Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy Adults

NCT02365532 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Long QT Syndrome

Interventions

DRUG: GS-6615
DRUG: Placebo to match GS-6615
DRUG: Placebo to match dofetilide
DRUG: Dofetilide

Sponsor

Gilead Sciences